|
|
Volumn 17, Issue 12, 2008, Pages 1791-1816
|
|
Discontinued drugs in 2007: Oncology drugs
|
|
Author keywords
ABJ 789; Advant; AG 24322; AG 858; ATRA; AZD 5896; CAT 3888; CAT 5001; CE 245677; CEP 7055; CP 868596; Epothilone D; Ethynylcytidine; Exisulind; GMK; Iboctadekin; Neovastat; NS 9; OSI 461; Siplizumab; Talotrexin; Telatinib; VX 667
|
|
Indexed keywords
3' ETHYNYLCYTIDINE;
5,6,7,13 TETRAHYDRO 12 (3 HYDROXYPROPYL) 9 ISOPROPOXYMETHYLINDENO[2,1 A]PYRROLO[3,4 C]CARBAZOL 5(12H) ONE DIMETHYLGLYCINE ESTER;
ABJ 789;
AE 941;
AG 24322;
AG 858;
ANTINEOPLASTIC AGENT;
AZD 5896;
BAY 57 9352;
CANCER VACCINE;
CAT 3888;
CAT 5001;
CB 001;
CE 245677;
CP 868596;
DIHYDROFOLATE REDUCTASE INHIBITOR;
DN 485232;
EPOTHILONE B;
EPOTHILONE D;
GMK;
GMK VACCINE;
HE 2100;
HE 3204;
HE 3235;
HE 3286;
IBOCTADEKIN;
INCYCLINIDE;
LOMEGUATRIB;
MK 6592;
NALPHA (4 AMINO 4 DEOXYPTEROYL) NDELTA HEMIPHTHALOYLORNITHINE;
NS 9;
OSI 461;
PROTEIN SYNTHESIS INHIBITOR;
RETINOIC ACID;
SEMAPIMOD;
SIPLIZUMAB;
STEM CELL FACTOR;
STEROID HORMONE;
SULINDAC SULFONE;
TALOTREXIN;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VISILIZUMAB;
ACUTE LUNG INJURY;
ADENOMATOUS POLYP;
ANTINEOPLASTIC ACTIVITY;
BONE MARROW SUPPRESSION;
BONE MARROW TOXICITY;
CANCER CHEMOTHERAPY;
CANCER GENE THERAPY;
CANCER IMMUNOTHERAPY;
CANCER PATIENT;
CHRONIC MYELOID LEUKEMIA;
CLINICAL TRIAL;
COLON POLYP;
COLORECTAL CANCER;
CUTANEOUS T CELL LYMPHOMA;
DRUG EFFICACY;
DRUG INDICATION;
DRUG STRUCTURE;
DRUG TARGETING;
DRUG TREATMENT FAILURE;
DRUG WITHDRAWAL;
ENTERITIS;
HAIRY CELL LEUKEMIA;
HUMAN;
KIDNEY CANCER;
LEUKEMIA;
LIVER CANCER;
LUNG NON SMALL CELL CANCER;
LYMPHOMA;
MELANOMA;
MESOTHELIOMA;
METASTASIS;
MUCOSA INFLAMMATION;
MULTIPLE MYELOMA;
MYELOID LEUKEMIA;
NEOPLASM;
PANCREAS CANCER;
PERIPHERAL T CELL LYMPHOMA;
PSORIASIS;
RETINA MACULA AGE RELATED DEGENERATION;
REVIEW;
ROSACEA;
SINGLE DRUG DOSE;
SKIN DISEASE;
TREATMENT RESPONSE;
TREATMENT WITHDRAWAL;
TUMOR;
VIRAL GENE DELIVERY SYSTEM;
VIRAL GENE THERAPY;
ARTICLE;
CHEMISTRY;
DRUG SCREENING;
TIME;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS AS TOPIC;
DRUG EVALUATION;
HUMANS;
NEOPLASMS;
TIME FACTORS;
|
|
EID: 58149394474
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543780802465737 Document Type: Review |
|
Times cited : (9)
|
|
References (7)
|
